Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.06 | $119.02B | $250.00B | $402.07B | $9.41B | $1.77B | 66.95x | 0.30x | 20.16x |
JN JNJ JOHNSON & JOHNSON FY ended Feb 06, 2026 | $268.04 | $645.95B | $703.36B | $94.19B | $37.95B | $26.80B | 24.30x | 6.86x | 17.67x |
BS BSX BOSTON SCIENTIFIC CORP FY ended Jan 30, 2026 | $46.84 | $67.88B | $79.12B | $20.07B | $5.10B | $2.89B | 24.14x | 3.38x | 14.60x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 18.14x | 4/4 | $9.31B | $10.60 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 3.90x | 4/4 | $24.02B | $27.36 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 38.69x | 4/4 | $24.18B | $27.55 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.06 | $119.02B | $250.00B | $402.07B | $9.41B | $1.77B | 66.95x | 0.30x | 20.16x |
JN JNJ JOHNSON & JOHNSON FY ended Feb 06, 2026 | $268.04 | $645.95B | $703.36B | $94.19B | $37.95B | $26.80B | 24.30x | 6.86x | 17.67x |
BS BSX BOSTON SCIENTIFIC CORP FY ended Jan 30, 2026 | $46.84 | $67.88B | $79.12B | $20.07B | $5.10B | $2.89B | 24.14x | 3.38x | 14.60x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 18.14x | 4/4 | $9.31B | $10.60 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 3.90x | 4/4 | $24.02B | $27.36 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 38.69x | 4/4 | $24.18B | $27.55 | Included in the active peer mix. |